Review



cjun inhibitor  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bio-Techne corporation cjun inhibitor
    Cjun Inhibitor, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 78 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cjun inhibitor/product/Bio-Techne corporation
    Average 94 stars, based on 78 article reviews
    cjun inhibitor - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    94
    Bio-Techne corporation cjun inhibitor
    Cjun Inhibitor, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cjun inhibitor/product/Bio-Techne corporation
    Average 94 stars, based on 1 article reviews
    cjun inhibitor - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    90
    Beyotime cjun n-terminal kinase (jnk) inhibitor (sp600125, purity>98
    Cjun N Terminal Kinase (Jnk) Inhibitor (Sp600125, Purity>98, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cjun n-terminal kinase (jnk) inhibitor (sp600125, purity>98/product/Beyotime
    Average 90 stars, based on 1 article reviews
    cjun n-terminal kinase (jnk) inhibitor (sp600125, purity>98 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Millipore cjun n-terminal kinase (jnk) inhibitor, sp600125
    Cjun N Terminal Kinase (Jnk) Inhibitor, Sp600125, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cjun n-terminal kinase (jnk) inhibitor, sp600125/product/Millipore
    Average 90 stars, based on 1 article reviews
    cjun n-terminal kinase (jnk) inhibitor, sp600125 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Enzo Biochem cjun n-terminal kinase (jnk) inhibitor sp600125
    Cjun N Terminal Kinase (Jnk) Inhibitor Sp600125, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cjun n-terminal kinase (jnk) inhibitor sp600125/product/Enzo Biochem
    Average 90 stars, based on 1 article reviews
    cjun n-terminal kinase (jnk) inhibitor sp600125 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology anti cjun antibody
    A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
    Anti Cjun Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cjun antibody/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    anti cjun antibody - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Tocris cjun n-terminal kinase (jnk) inhibitor sp 600125
    A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
    Cjun N Terminal Kinase (Jnk) Inhibitor Sp 600125, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cjun n-terminal kinase (jnk) inhibitor sp 600125/product/Tocris
    Average 90 stars, based on 1 article reviews
    cjun n-terminal kinase (jnk) inhibitor sp 600125 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Millipore sp600125, an inhibitor of cjun n terminal kinase (jnk) mapk
    A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
    Sp600125, An Inhibitor Of Cjun N Terminal Kinase (Jnk) Mapk, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sp600125, an inhibitor of cjun n terminal kinase (jnk) mapk/product/Millipore
    Average 90 stars, based on 1 article reviews
    sp600125, an inhibitor of cjun n terminal kinase (jnk) mapk - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Millipore jnk (cjun n-terminal kinase) inhibitor ii (sp600125)
    A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
    Jnk (Cjun N Terminal Kinase) Inhibitor Ii (Sp600125), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/jnk (cjun n-terminal kinase) inhibitor ii (sp600125)/product/Millipore
    Average 90 stars, based on 1 article reviews
    jnk (cjun n-terminal kinase) inhibitor ii (sp600125) - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    86
    New England Biolabs phosphospecific cjun antibody kit
    A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using <t>anti-cJun</t> (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. <t>B:</t> <t>Chromatin</t> Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.
    Phosphospecific Cjun Antibody Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphospecific cjun antibody kit/product/New England Biolabs
    Average 86 stars, based on 1 article reviews
    phosphospecific cjun antibody kit - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    Image Search Results


    A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using anti-cJun (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. B: Chromatin Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.

    Journal: PLoS ONE

    Article Title: p21-Activated Kinase 3 (PAK3) Is an AP-1 Regulated Gene Contributing to Actin Organisation and Migration of Transformed Fibroblasts

    doi: 10.1371/journal.pone.0066892

    Figure Lengend Snippet: A: Electrophoretic Mobility Shift Assay (EMSA) showing protein binding to the (+52/+60) PAK3 promoter region. Lane 1 shows the presence of a DNA/protein complex when the (+52/+60) PAK3 promoter radioactively-labelled oligomer was incubated with protein cell lysate of Rat1a-J4 cells treated with doxycycline. This DNA/protein complex could be competed for with unlabelled (+52/+60) wild-type (WT) oligomers (lane 2), but not with a mutated (+52/+60) sequence oligomer (lane 3). The second panel shows supershifted complexes using anti-cJun (lane 4), -JunB (lane 5) and –JunD (lane 6) antibodies. B: Chromatin Immunoprecipitation Assay (ChIP) showing cJun binding to the (+52/+60) PAK3 promoter region. Rat1a-J4 cells were treated with doxycycline for 48 hrs, after which DNA and protein complexes were cross-linked and pulled down with an anti-cJun antibody. RT-PCR amplification off the pulled-down chromatin showed cJun binding to the (+52/+60) PAK3 promoter region in the presence of doxycycline.

    Article Snippet: Lysates was then diluted with dilution buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-Cl, pH 8.1, 1 X Complete Protease Inhibitor) and chromatin was either immunoprecipitated with or without anti-cJun antibody (sc-44 (Santa Cruz)) and treated with pre-blocked protein-A agarose beads (Merck).

    Techniques: Electrophoretic Mobility Shift Assay, Protein Binding, Incubation, Sequencing, Chromatin Immunoprecipitation, Binding Assay, Reverse Transcription Polymerase Chain Reaction, Amplification